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Abstract
Virulence of Helicobacter pylori , H. Suis  and other 
bacteria appears to be partly mediated through a re-
lease of gamma-glutamyltransferase (GGT), an enzyme 
activity capable of promoting biochemical reactions 
ultimately resulting in damage to gastric epithelium and 
suppression of immune response. Recently published 
studies show that secretion of bacterial GGT occurs in 
the form of exosome-like vescicles. Very similar GGT-
rich exosomes have been described to originate from 
human cancer cells, and the hypothesis is thus forwar-
ded that in the resistant and invasive phenotype of 
malignant cells such vescicular/exosomal GGT may play 
roles akin to those described for Helicobacter  infection, 
thus providing a significant contribution to the esta-
blishment of cancer metastases.
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Core tip: Biochemical reactions promoted by gamma-
glutamyltransferase (GGT) of Helicobacter  is capable 
of causing damage to gastric epithelium and suppres-
sion of immune response. Bacterial GGT is secreted as 
exosome-like vescicles, and very similar GGT-rich exo-
somes are released from human cancer cells. In the re-
sistant and invasive phenotype of malignant cells, such 
secreted GGT may play roles akin to those described 
for Helicobacter  infection, concurring to the establish-
ment of cancer metastases.
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TO THE EDITOR
The recent Topic Highlight article by Ricci et al[1] is a tho-
rough and comprehensive scrutiny of  the mechanisms 
possibly underlying the recently reported implication of  
Helicobacter pylori (H. pylori) gamma-glutamyltransferase 
(GGT) as a virulence factor. The authors discuss how-
among other effects-H. pylori GGT causes glutathione 
consumption and reactive oxygen species generation 
in the host cells, thus causing in turn cell-cycle arrest, 
apoptosis, and necrosis in gastric epithelial cells. Impor-
tantly, GGT also induces immune tolerance through the 
inhibition of  T cell-mediated immunity and dendritic cell 
differentiation, overall favouring H. pylori persistence and 
gastric colonization[1].
Now, secretion of  GGT appears to also occur by 
other bacteria related with gastric diseases, e.g., Campylo-
bacter jejunii[2], and recent reports are adding intriguing 
observations. Zhang et al[3] have shown that GGT of  H. 
Suis-a related Helicobacter, also involved in gastric patho-
logy - is secreted in the form of  bacterial outer membra-
ne vescicles (OMV), i.e., submicroscopic structures 20-50 
nm in diameter normally budding from the cell surface. 
These OMV’s can translocate across the epithelial layers 
and deliver GGT enzyme to the lymphocytes residing in 
the lamina propria of  gastric mucosa. As a result, inhibi-
tion of  lymphocyte proliferation is induced, and bacterial 
invasion and proliferation are facilitated.
The association of  bacterial GGT enzyme with OMV’s 
may be the factor determining its targeting to host lym-
phocytes, but additional studies are needed to verify this 
point. In any case, one aspect of  the matter calling for at-
tention is represented by the connections possibly linking 
these observations with data stemming from oncologic 
research. Interestingly enough, secretion of  similar GGT-
containing submicroscopic particles has in fact been 
documented also from eukaryotic cells, and remarkably, 
from human cancer cells. GGT activity is expressed in a 
number of  human malignancies, and increasing levels are 
usually detectable along with progression of  the disease 
and in metastases[4,5]. GGT activity of  cancer cells can af-
fect intracellular redox equilibria, along with modulatory 
effects on the S-thiolation status of  extracellular pro-
teins[6], including cell surface receptors related with the 
cell survival/apoptosis balance[7]. Recent studies from our 
laboratory[8,9] have shown that active GGT can be relea-
sed from cancer cells in association with vesicles similar 
to exosomes, 20-40 nm in diameter. The resemblance of  
such structures with GGT-rich OMV particles of  H. suis 
is indeed obvious.
Thus, in the light of  the mentioned studies on the 
virulence of  H. pylori, the intriguing hypothesis could be 
forwarded that GGT-rich exosomes released by cancer 
cells can produce-in host’s surrounding tissues-effects 
comparable to those apparent for bacterial GGT, i.e., de-
pletion of  glutathione, oxidative stress and perturbation/
suppression of  immune response. This could contribute 
significantly to the increased ability of  malignant cells to 
survive and colonize host’s tissues, thus at least partially 
explaining the reportedly higher metastatic potential of  
GGT-expressing tumors[4]. The potential role in tumor 
evolution of  GGT released by gastric cancer cells has 
not been investigated to date. Nevertheless, basing on the 
considerations above, clinical studies specifically addres-
sing this point are warranted.
In conclusion, the GGT-dependent processes docu-
mented in bacterial virulence as well as in biology of  ma-
lignant tumors may represent an example of  “convergent 
evolution”-in unrelated species, and in different cells of  
the same species-of  closely related molecular strategies, 
aimed at improving the survival and expansion of  cellular 
populations in the context of  a hostile/resisting environ-
ment. Future investigation will hopefully further elucidate 
these fascinating phenomena.
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